Twist Bioscience (TWST) Asset Writedowns and Impairment (2017 - 2024)
Twist Bioscience (TWST) posted quarterly Asset Writedowns and Impairment of $293000.0 for Q3 2024, down 80.89% year-over-year from $1.5 million in Q4 2023, and up 103.47% quarter-over-quarter from $144000.0 in Q2 2024.
Twist Bioscience (TWST) Asset Writedowns and Impairment (2017 - 2024) Analysis & Trends
Twist Bioscience (TWST) has reported Asset Writedowns and Impairment for 8 consecutive years, with $293000.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Asset Writedowns and Impairment fell 80.89% year-over-year to $293000.0; the TTM figure through Sep 2024 stood at $940000.0 (down 63.47% YoY), while the FY2025 annual figure was -$20000.0, down 102.13% from the prior year.
- Asset Writedowns and Impairment rose to $293000.0 in Q3 2024 per TWST's latest filing, from $144000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $17.5 million in Q3 2022 and bottomed at -$1.0 million in Q3 2020.
- Historically, Asset Writedowns and Impairment has averaged $1.3 million across 5 years, with a median of $255000.0 in 2024.
- Annual changes were most pronounced in 2020 — Asset Writedowns and Impairment tumbled 2145.1% — and 2021, when it surged 4596.0%.
- Twist Bioscience's Asset Writedowns and Impairment stood at $25000.0 in 2020, then soared by 4596.0% to $1.2 million in 2021, then plunged by 78.36% to $254000.0 in 2022, then retreated by 2.36% to $248000.0 in 2023, then grew by 18.15% to $293000.0 in 2024.
- Business Quant data shows TWST's Asset Writedowns and Impairment at $293000.0 in Q3 2024, $144000.0 in Q2 2024, and $255000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Twist Bioscience | 7.18 Bn | 7.02 Bn | 62.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 293,000.00 |
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Dec 31, 2023 | 248,000.00 |
| Dec 31, 2023 | 248,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 454,000.00 |
| Jun 30, 2023 | 454,000.00 |
| Mar 31, 2023 | 332,000.00 |
| Mar 31, 2023 | 332,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 17.53 Mn |
| Sep 30, 2022 | 17.53 Mn |
| Jun 30, 2022 | 985,000.00 |
| Jun 30, 2022 | 985,000.00 |